Matthen Mathew

521 total citations
13 papers, 321 citations indexed

About

Matthen Mathew is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Matthen Mathew has authored 13 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Matthen Mathew's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Matthen Mathew is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Matthen Mathew collaborates with scholars based in United States, Canada and Australia. Matthen Mathew's co-authors include Naiyer A. Rizvi, Catherine A. Shu, Thomas Enzler, Fatemeh Momen‐Heravi, Romil Patel, Yu Wang, Angela J. Yoon, Alison M. Taylor, Xun Wu and Yi‐Shing Lisa Cheng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Matthen Mathew

12 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthen Mathew United States 8 165 130 108 87 58 13 321
Perrine Garde‐Granger Canada 11 166 1.0× 125 1.0× 117 1.1× 52 0.6× 36 0.6× 12 349
Ahmed Raji Iraq 3 204 1.2× 97 0.7× 132 1.2× 42 0.5× 68 1.2× 8 319
Sadaf Mehdizadeh United States 3 182 1.1× 103 0.8× 118 1.1× 40 0.5× 39 0.7× 6 298
Qinglin Fei China 8 210 1.3× 134 1.0× 185 1.7× 52 0.6× 40 0.7× 16 362
Apostolos C Ziogas Greece 5 148 0.9× 122 0.9× 96 0.9× 50 0.6× 42 0.7× 32 315
Songwei Feng China 11 84 0.5× 130 1.0× 61 0.6× 69 0.8× 75 1.3× 21 266
Qing Jiang China 7 130 0.8× 104 0.8× 68 0.6× 74 0.9× 71 1.2× 12 292
Rami Mustapha United Kingdom 9 159 1.0× 194 1.5× 183 1.7× 138 1.6× 41 0.7× 17 399
Xunbin Yu China 6 144 0.9× 78 0.6× 129 1.2× 47 0.5× 30 0.5× 16 281
Joseph E. Grossman United States 8 193 1.2× 62 0.5× 77 0.7× 49 0.6× 58 1.0× 30 290

Countries citing papers authored by Matthen Mathew

Since Specialization
Citations

This map shows the geographic impact of Matthen Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthen Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthen Mathew more than expected).

Fields of papers citing papers by Matthen Mathew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthen Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthen Mathew. The network helps show where Matthen Mathew may publish in the future.

Co-authorship network of co-authors of Matthen Mathew

This figure shows the co-authorship network connecting the top 25 collaborators of Matthen Mathew. A scholar is included among the top collaborators of Matthen Mathew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthen Mathew. Matthen Mathew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hilton, John, Patrick A. Ott, Aaron R. Hansen, et al.. (2024). INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer Immunology Immunotherapy. 73(3). 44–44. 10 indexed citations
2.
To, Minh D., Victoria Atkinson, Philippe L. Bédard, et al.. (2023). 760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors. SHILAP Revista de lepidopterología. A856–A856. 1 indexed citations
3.
Bukhari, Shoiab, Brian S. Henick, Robert Winchester, et al.. (2022). Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors. Cell Reports Medicine. 4(1). 100868–100868. 41 indexed citations
4.
Wu, Xun, Yi‐Shing Lisa Cheng, Matthen Mathew, et al.. (2021). Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion. Journal of Experimental & Clinical Cancer Research. 40(1). 70–70. 48 indexed citations
5.
Spivack, John, Anjali Saqi, Luke Benvenuto, et al.. (2020). Characteristics and outcomes of lung cancer in solid organ transplant recipients. Lung Cancer. 146. 297–302. 7 indexed citations
6.
7.
Campbell, Matthew T., Tian Zhang, Lynda Chin, Allison Betof Warner, & Matthen Mathew. (2020). ApricityRx companion digital therapeutic for evidence-based mitigation and phenotype-linked molecular characterization of irAEs in patients receiving immune checkpoint therapy (ICT).. Journal of Clinical Oncology. 38(15_suppl). TPS2089–TPS2089. 3 indexed citations
8.
9.
Mathew, Matthen, et al.. (2020). Extracellular Vesicles as Biomarkers in Cancer Immunotherapy. Cancers. 12(10). 2825–2825. 79 indexed citations
10.
11.
Mathew, Matthen, Thomas Enzler, Catherine A. Shu, & Naiyer A. Rizvi. (2018). Combining chemotherapy with PD-1 blockade in NSCLC. Pharmacology & Therapeutics. 186. 130–137. 100 indexed citations
12.
Safyan, Rachael A., Matthen Mathew, Enrica Marchi, & Melissa Accordino. (2017). Bone marrow aspirate quality assessment.. Journal of Clinical Oncology. 35(8_suppl). 76–76. 1 indexed citations
13.
Mathew, Matthen, et al.. (1984). Donor-specific suppressor cells and donor-specific loss of cell-mediated lympholysis in renal allograft recipients: a comparative study.. PubMed. 16(6). 1478–80.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Perrine Garde‐Granger Breakdown of academic impact, for papers by Ahmed Raji Breakdown of academic impact, for papers by Sadaf Mehdizadeh Breakdown of academic impact, for papers by Qinglin Fei Breakdown of academic impact, for papers by Apostolos C Ziogas Breakdown of academic impact, for papers by Songwei Feng Breakdown of academic impact, for papers by Qing Jiang Breakdown of academic impact, for papers by Rami Mustapha Breakdown of academic impact, for papers by Xunbin Yu Breakdown of academic impact, for papers by Joseph E. Grossman
Rankless by CCL
2026